Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...
MyCareGorithm was met with high approval from patients, companions, and physicians, with all 3 groups reporting they’d ...
Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...
Philips (NYSE: PHG) today announced the release of new Elevate software to enhance workflows for its ultrasound imaging ...
StarsInsider on MSN7h
Cancer screening: what tests you should be doing and whenCancer affects millions of people throughout the world. Though there are some things we can do to try and prevent it, such as ...
Annual Symposium held in San Francisco, CA between February 13–15, 2025 was host to a prostate cancer poster session. Dr. Ida Sonni presented a study evaluating the diagnostic performance of 18 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback